From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis.
暂无分享,去创建一个
I. Kariv | S. Mandlekar | A. Tebben | C. Decicco | P. Carter | J. Duncia | J. Santella | C. Shi | S. Yeleswaram | W. Yao | E. Wadman | K. Solomon | Danielle M Graden | P. S. Watson | S. Ko | P. Welch | P. Reddy | D. Gardner | D. A. Wacker | P. Davies | G. Delucca | Dean A Wacker | Paul S. Watson | George V. Delucca
[1] P. Wipf,et al. Origins of the high 14-helix propensity of cyclohexyl-rigidified residues in beta-peptides. , 2007, Organic letters.
[2] G. Trainor,et al. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. , 2005, Journal of medicinal chemistry.
[3] S. Escher,et al. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases , 2004, Allergy.
[4] G. Trainor,et al. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists. , 2004, Bioorganic & medicinal chemistry letters.
[5] P. Barnes,et al. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. , 2002, Current drug targets. Inflammation and allergy.
[6] C. Owen. Chemokine receptors in airway disease: which receptors to target? , 2001, Pulmonary pharmacology & therapeutics.
[7] C. Corrigan. The eotaxins in asthma and allergic inflammation: implications for therapy. , 2000, Current opinion in investigational drugs.
[8] C. Bertrand,et al. CCR3 blockade as a new therapy for asthma , 2000, Expert opinion on investigational drugs.
[9] B. Jaun,et al. β2‐ and β3‐Peptides with Proteinaceous Side Chains: Synthesis and solution structures of constitutional isomers, a novel helical secondary structure and the influence of solvation and hydrophobic interactions on folding , 1998 .
[10] D J Rance,et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.
[11] B. W. Gung,et al. Conformational Study of Succinic and Glutaric β-Alanine Derivatives: Resistance of β-Alanine Amides To Form Intramolecular Hydrogen Bonds , 1997 .
[12] S. Davies,et al. Asymmetric Synthesis of (2S,3S)- and (2R,3S)-2,3-Diaminobutanoic Acids, Non-Protein Amino-Acid Diastereomers found in a number of Peptide Antibiotics , 1996 .
[13] P. Beaulieu,et al. Preparation of Aminoalkyl Chlorohydrin Hydrochlorides: Key Building Blocks for Hydroxyethylamine-Based HIV Protease Inhibitors. , 1996, The Journal of organic chemistry.
[14] S. Davies,et al. Asymmetric synthesis of anti-α-alkyl-β-amino acids , 1994 .
[15] M. Bunnage,et al. Asymmetric synthesis of β-amino-α-hydroxy acids via diastereoselective hydroxylation of homochiral β-amino enolates , 1994 .
[16] F. A. Davis,et al. Chemistry of oxaziridines. 18. Synthesis and enantioselective oxidations of the [(8,8-dihalocamphoryl)sulfonyl]oxaziridines , 1992 .
[17] R. W. Hoffmann,et al. Allylic 1,3-strain as a controlling factor in stereoselective transformations , 1989 .
[18] A. Cerami,et al. Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analogues. , 1984, Journal of medicinal chemistry.